REACT assesses clazosentan for the prevention of clinical deterioration due to vasospasm-related delayed cerebral ischemia following subarachnoid hemorrhage Japanese registration program with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback